FAQs

A: Interspond works with a network of Sites and provides centralized business development activities. We identify study opportunities for Sites and provide top enrolling, high performing Sites to Sponsors and CROs for consideration for participation.

A: Interspond considers multiple factors including, but not limited to:  PI and staff research experience, relevant study metrics, Site location, therapeutic specialties, SOP regulations, and use of Central IRB.

A: No. Interspond works with a network of Sites on a study-by-study basis.

A: No, we only work with Sites in the USA.

A: No.

A: There are 140+ Sites in our network.

A: Interspond does not oversee the PIs.

A: Yes. We are listed as party to the contract and are the payee.

A: Yes, we track a variety of different metrics.

A: Interspond can never guarantee subject enrollment.  However, we guarantee that we rigorously vet the sites we recommend for participation. This will lead to a high probability that they will successfully enroll subjects.

A: There is NO COST to work with Interspond. Interspond does not charge any direct fees to the Sponsor or CRO.

A: No, CROWN was developed specifically for Sites in our network for the purpose of study feasibility.

A: No. Confidential information is only posted after CDAs have been executed.

A: No. Once the site has been selected by the Sponsor and the contract and budget has been executed, the Site will become the main contact for the duration of the study.

A: No. Please see our list of therapeutic areas.

A: Interspond works with a network of Sites and provides centralized business development activities. We identify study opportunities for Sites and provide top enrolling, high performing Sites to Sponsors andCROs for consideration for participation.

A: There are 140+ Sites in our network.

A: Prospective Sites meet with the Site Relations team to discuss Site capabilities.  Interspond’s business model is explained and the Site must agree to work with Interspond in that capacity. Approved Sites are then invited to complete their profile in CROWN.

A: No. Interspond does not require Sites to sign a contract to join our network. Sites will sign an Agreement Statement and a CTA on a study-by-study basis.

A: There is NO COST to work with Interspond. Interspond does not charge any fees to Sites or take a percentage of the budget. Sites are paid exactly the per-patient amount that was negotiated with Interspond.

A: Yes. Interspond does not expect an exclusive arrangement with Sites.

A: No.

A: No. Please see our list of therapeutic areas.

A: Interspond negotiates a budget with the Sponsor/CRO and a different budget with the Sites. The budget negotiated with the Sponsor/CRO is confidential.

A: Interspond pays Sites per the terms of the contract upon receipt of funds (and break-down) from the Sponsor or CRO. Checks are cut weekly and detailed break-downs are sent via email.

A: Historically Interspond has posted approximately 20 studies per month. The number of studies presented is dependent upon the Sponsor’s and CRO’s pipelines.

A: Interspond expects that Sites will work with the company that initially presented the study to them.

A: Sponsors and CROs are the decision makers on which Sites are selected for each study.

A: Once a Site has been approved to be part of the Interspond network, access will be provided.

A: No. Once the site has been selected by the Sponsor and the contract and budget has been executed, the Site will become the main contact for the duration of the study.

A: Written procedures are provided to Sites. Interspond staff are happy to assist as needed.